Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study
Authors:
- 9 August 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 277, 116758
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Interaction mechanisms of ACE inhibitory peptides: molecular docking and molecular dynamics simulation studies on five wheat gluten derived peptidesEuropean Food Research and Technology, 2024
- Screening for Q-markers of Antiviral Granules based on neuraminidase inhibitors and Effect-constituent indexArabian Journal of Chemistry, 2024
- On a Fractal–Fractional-Based Modeling for Influenza and Its Analytical ResultsQualitative Theory of Dynamical Systems, 2024
- Development of anti‐influenza agents from natural productsMedicinal Research Reviews, 2020
- Naringenin, a flavanone with antiviral and anti‐inflammatory effects: A promising treatment strategy against COVID‐19Phytotherapy Research, 2020
- Bioactive phenolic fraction of Citrus maxima abate lipopolysaccharide-induced sickness behaviour and anorexia in mice: In-silico molecular docking and dynamic studies of biomarkers against NF-κBBiomedicine & Pharmacotherapy, 2018
- A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small MoleculesChemMedChem, 2016
- The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes familyMolecular Biology Reports, 2014
- Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activitiesBioorganic & Medicinal Chemistry, 2009
- Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activitiesBioorganic & Medicinal Chemistry, 2008